Innate Pharma
IPHA
#8351
Rank
S$0.22 B
Marketcap
$2.60
Share price
0.00%
Change (1 day)
-22.32%
Change (1 year)

EPS for Innate Pharma (IPHA)

EPS in 2022: -$1.03

According to Innate Pharma 's latest financial reports the company's current EPS (TTM) is -$1.03. In 2022 the company made an earnings per share (EPS) of -$1.03 a decrease over its 2021 EPS that were of -$0.98.

EPS history for Innate Pharma from 2005 to 2022

Annual EPS

Year EPS Change
2022-$1.034.6%
2021-$0.98-24.98%
2020-$1.31186.89%
2019-$0.46-707.12%
2018$0.07522-105.35%
2017-$1.41-541.28%
2016$0.32-270.34%
2015-$0.19-70.03%
2014-$0.62390.66%
2013-$0.13-8.65%
2012-$0.14-57.03%
2011-$0.32-48.58%
2010-$0.63-40.32%
2009-$1.0624.76%
2008-$0.8522.34%
2007-$0.6916.95%
2006-$0.59-7.23%
2005-$0.64